Inventor · disambiguated record
Michael Bennett
Also filed as: BENNETT MICHAEL · BENNETT MICHAEL J · BENNETT MICHAEL JOHN
21 granted patents·11 pending applications·576 citations·filing 1993–2022
96Inventor score
Files withGENTERIC INC8UNIV CALIFORNIA6CELGENE QUANTICEL RES INC4AGOURON PHARMA3BOYLAN JOHN FREDERICK2
Top patents by PatentIndex Score
32 records- 0196US5346907AAmino acid analog CCK antagonistsABBOTT LAB·Filed 1993·Granted Sep 13, 1994·94 cites·6 claims
- 0294US9034900B2Bromodomain inhibitorsQuanticel Pharmaceuticals·Filed 2014·Granted May 19, 2015·36 cites·30 claims
- 0394US5824812APolyfunctional cationic cytofectins, formulations and methods for generating active cytofectin: polynucleotide transfection complexesUNIV CALIFORNIA·Filed 1996·Granted Oct 20, 1998·62 cites·40 claims
- 0494US5744625ACationic transport reagentsUNIV CALIFORNIA·Filed 1996·Granted Apr 28, 1998·57 cites·4 claims
- 0593US9115114B2Bromodomain inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 25, 2015·12 cites·30 claims
- 0693US5869715APolyfunctional cationic cytofectinsUNIV CALIFORNIA·Filed 1995·Granted Feb 9, 1999·54 cites·4 claims
- 0791US7132533B2Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapyAGOURON PHARMA·Filed 2005·Granted Nov 7, 2006·21 cites·3 claims
- 0891US5527928ACationic transport reagentsFiled 1994·Granted Jun 18, 1996·99 cites·4 claims
- 0990US7462713B2Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapyAGOURON PHARMA·Filed 2006·Granted Dec 9, 2008·18 cites·9 claims
- 1089US10883103B2Compositions and methods for delivery of a polynucleotide into a plantMONSANTO TECHNOLOGY LLC·Filed 2016·Granted Jan 5, 2021·4 cites·8 claims
- 1188US5892071ACationic transport reagentsUNIV CALIFORNIA·Filed 1995·Granted Apr 6, 1999·36 cites·22 claims
- 1285US10807982B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2019·Granted Oct 20, 2020·2 cites·14 claims
- 1385US9908885B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Mar 6, 2018·4 cites·24 claims
- 1481US6967198B2Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapyAGOURON PHARMA·Filed 2004·Granted Nov 22, 2005·17 cites·37 claims
- 1581US6372722B1Method for nucleic acid transfection of cellsGENTERIC INC·Filed 2000·Granted Apr 16, 2002·12 cites·43 claims
- 1678US5925623AFormulations and methods for generating active cytofectin: polynucleotide transfection complexesUNIV CALIFORNIA·Filed 1996·Granted Jul 20, 1999·43 cites·5 claims
- 1776US10494371B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Dec 3, 2019·1 cites·31 claims
- 1871US10202360B2Therapeutic compoundsCELGENE QUANTICEL RES INC·Filed 2017·Granted Feb 12, 2019·1 cites·29 claims
- 1968US6624149B2Method for nucleic acid transfection of cellsGENTERIC INC·Filed 2001·Granted Sep 23, 2003·2 cites·51 claims
- 2053US2024189446A1Compositions and methods for delivery of nucleic acidsPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2150US2005043258A1Methods of treating xerostomia and xerophthalmiaGENTERIC INC·Filed 2004·Application pending·0 cites
- 2249US2004116370A1Retroductal salivary gland genetic vaccinationGENTERIC INC·Filed 2003·Application pending·0 cites
- 2347US2010093696A12-amino pyrimidine compoundsPFIZER·Filed 2008·Application pending·0 cites
- 2447US2004043952A1Multifunctional polyamines for delivery of biologically-active polynucleotidesGENTERIC INC·Filed 2003·Application pending·0 cites
- 2546US2013072543A1Compounds and Compositions for Nucleic Acid Formulation and DeliveryBOYLAN JOHN FREDERICK·Filed 2012·Application pending·0 cites
- 2645US2013079383A1Lipid Compounds Targeting VLA-4BOYLAN JOHN FREDERICK·Filed 2012·Application pending·0 cites
- 2743US2003198625A1Electroporation-mediated transfection of the salivary glandGENTERIC INC·Filed 2002·Application pending·0 cites
- 2839US2004092473A1Method for nucleic acid transfection of cellsGENTERIC INC·Filed 2003·Application pending·0 cites
- 2939US2003175966A1Cationic sugar derivatives for gene transferGENTERIC INC·Filed 2002·Application pending·0 cites
- 3038US11807857B2Methods and compositions for delivering nucleic acids to plant cells and regulating gene expressionMONSANTO TECHNOLOGY LLC·Filed 2015·Granted Nov 7, 2023·0 cites·12 claims
- 3138US6025358ADouble prodrugs of potent GP IIb/IIIa antagonistsSEARLE & CO·Filed 1999·Granted Feb 15, 2000·1 cites·8 claims
- 3237US2004077888A1Polyamine-mediated transfectionUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Bennett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →